134 related articles for article (PubMed ID: 26690701)
1. A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.
Fuentes RE; Zaitsev S; Ahn HS; Hayes V; Kowalska MA; Lambert MP; Wang Y; Siegel DL; Bougie DW; Aster RH; Myers DD; Stepanova V; Cines DB; Muzykantov VR; Poncz M
J Clin Invest; 2016 Feb; 126(2):483-94. PubMed ID: 26690701
[TBL] [Abstract][Full Text] [Related]
2. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation.
Zaitsev S; Spitzer D; Murciano JC; Ding BS; Tliba S; Kowalska MA; Marcos-Contreras OA; Kuo A; Stepanova V; Atkinson JP; Poncz M; Cines DB; Muzykantov VR
Blood; 2010 Jun; 115(25):5241-8. PubMed ID: 20410503
[TBL] [Abstract][Full Text] [Related]
3. Delivery of anti-platelet-endothelial cell adhesion molecule single-chain variable fragment-urokinase fusion protein to the cerebral vasculature lyses arterial clots and attenuates postischemic brain edema.
Danielyan K; Ding BS; Gottstein C; Cines DB; Muzykantov VR
J Pharmacol Exp Ther; 2007 Jun; 321(3):947-52. PubMed ID: 17389242
[TBL] [Abstract][Full Text] [Related]
4. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
[TBL] [Abstract][Full Text] [Related]
5. A long-acting PAI-1 inhibitor reduces thrombus formation.
Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets.
Kufrin D; Eslin DE; Bdeir K; Murciano JC; Kuo A; Kowalska MA; Degen JL; Sachais BS; Cines DB; Poncz M
Blood; 2003 Aug; 102(3):926-33. PubMed ID: 12689937
[TBL] [Abstract][Full Text] [Related]
7. A recombinant antibody-targeted plasminogen activator with high affinity for activated platelets increases thrombolytic potency in vitro and in vivo.
Wan H; Liu Z; Xia X; Gu J; Wang B; Liu X; Zhu M; Li P; Ruan C
Thromb Res; 2000 Feb; 97(3):133-41. PubMed ID: 10680644
[TBL] [Abstract][Full Text] [Related]
8. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
[TBL] [Abstract][Full Text] [Related]
9. Packaging of supplemented urokinase into alpha-granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.
Poncz M; Zaitsev S; Ahn H; Kowalska MA; Bdeir K; Dergilev KV; Ivanciu L; Camire RM; Cines DB; Stepanova V
Blood Adv; 2024 May; ():. PubMed ID: 38805575
[TBL] [Abstract][Full Text] [Related]
10. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.
Song Y; Bienvenu LA; Bongcaron V; Prijaya SA; Maluenda AC; Walsh APG; McFayden JD; Pietersz GA; Peter K; Wang X
Theranostics; 2024; 14(8):3267-3281. PubMed ID: 38855181
[No Abstract] [Full Text] [Related]
11. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
12. Packaging of supplemented urokinase into naked alpha-granules of
Poncz M; Zaitsev SV; Ahn H; Kowalska MA; Bdeir K; Camire RM; Cines DB; Stepanova V
bioRxiv; 2023 Dec; ():. PubMed ID: 38106191
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
Bai X; Weitz JI; Gross PL
Thromb Haemost; 2009 Dec; 102(6):1212-8. PubMed ID: 19967153
[TBL] [Abstract][Full Text] [Related]
14. The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.
Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
Br J Pharmacol; 2000 Oct; 131(4):858-64. PubMed ID: 11030738
[TBL] [Abstract][Full Text] [Related]
15. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
[TBL] [Abstract][Full Text] [Related]
17. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.
Pisapia JM; Xu X; Kelly J; Yeung J; Carrion G; Tong H; Meghan S; El-Falaky OM; Grady MS; Smith DH; Zaitsev S; Muzykantov VR; Stiefel MF; Stein SC
Exp Neurol; 2012 Jan; 233(1):357-63. PubMed ID: 22079156
[TBL] [Abstract][Full Text] [Related]
18. Prolonged half-life in the circulation of a chemical conjugate between a pro-urokinase derivative and human serum albumin.
Breton J; Pezzi N; Molinari A; Bonomini L; Lansen J; Gonzalez De Buitrago G; Prieto I
Eur J Biochem; 1995 Aug; 231(3):563-9. PubMed ID: 7649155
[TBL] [Abstract][Full Text] [Related]
19. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Loza JP; Gurewich V; Johnstone M; Pannell R
Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
[TBL] [Abstract][Full Text] [Related]
20. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
